(R)-N-(1-(4-Bromophenyl)ethyl)-2,2,2-trifluoroacetamide

Catalog No. :
ACOLZH532
CAS No. :
871720-04-6
Molecular Formula :
C10H9BrF3NO
Molecular Weight :
296.09

IUPAC Name:(R)-N-(1-(4-bromophenyl)ethyl)-2,2,2-trifluoroacetamide

(R)-N-(1-(4-Bromophenyl)ethyl)-2,2,2-trifluoroacetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$671.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-N-(1-(4-Bromophenyl)ethyl)-2,2,2-trifluoroacetamide
IUPAC Name(R)-N-(1-(4-bromophenyl)ethyl)-2,2,2-trifluoroacetamide
MDL No.MFCD15474865
Molecular FormulaC10H9BrF3NO
Molecular Weight296.09
SMILESO=C(N[C@@H](C1=CC=C(Br)C=C1)C)C(F)(F)F
InChI KeySHSKNAGOEXFZER-ZCFIWIBFSA-N
SynonymAcetaMide, N-[(1R)-1-(4-broMophenyl)ethyl]-2,2,2-trifluoro-;(R)-N-[1-(4-Bromo-phenyl)-ethyl]-2,2,2-trifluoro-acetamide;N-[(1R)-1-(4-Bromophenyl)ethyl]-2,2,2-trifluoro-acetamide
CAS No.871720-04-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACOLZH532 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCRJB491 route compound structure diagram
    ACCRJB49145791-36-4
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOLZH532 route product structure diagram
    ACOLZH532871720-04-6
Inquiry

2. ACOLZH532 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBTRO947 route compound structure diagram
    ACBTRO9473789-59-1 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACOLZH532 route product structure diagram
    ACOLZH532871720-04-6
Inquiry

Comments (0)